Measurements of IL-6 and TNF-alpha in tuberculosis and malignant effusion
Lu, Y.D.; Chen, P.; Fan, J.Z.
Hunan Yi Ke da Xue Xue Bao 25(3): 306; 308
2000
ISSN/ISBN: 1000-5625 PMID: 12212180 Document Number: 524505
Document emailed within 1 workday
Related Documents
Houston, M.C. 1981: Pleural effusion: diagnostic value of measurements of PO2, PCO2, and pH Southern Medical Journal 74(5): 585-589Mårtensson, G.; Pettersson, K.; Thiringer, G. 1985: Differentiation between malignant and non-malignant pleural effusion European Journal of Respiratory Diseases 67(5): 326-334
Cusumano, G.; Margaritora, S.; Porziella, V.; Meacci, E.; Piraino, A.; Vita, M.L.; Tessitore, A.; Congedo, M.T.; Filotico, M.; Cafarotti, S.; Granone, P. 2007: Malignant pleural effusion Annali Italiani di Chirurgia 78(5): 389-391
Moores, D.W. 1994: Management of the malignant pleural effusion Chest Surgery Clinics of North America 4(3): 481-495
Takada, M.; Fukuoka, M. 1989: Treatment of malignant pleural effusion Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(2): 165-172
Chaturvedi, A.; Kumar, A. 2017: Malignant Pleural Effusion with Filariasis Journal of the Association of Physicians of India 65(5): 106-107
Molendijk, L.W. 1997: Pleurodesis in malignant pleural effusion Nederlands Tijdschrift Voor Geneeskunde 141(46): 2257
Romero, S.; Hernández, L.; Salar, A.; García-Sevila, R.; Espasa, M.A.; Martín-Serrano, C. 1992: Value of the determination of CA 15-3 in the diagnosis of malignant pleural effusion Revista Clinica Espanola 190(7): 339-343
Salamon, P.; Berliner, S.; Shachner, A.; Pinkhas, J. 1989: Tetracycline treatment for malignant pericardial effusion Medecine Interne 27(1): 73-74
Bairy, K.L.; Sanath, S.; Jagetia, G.C.; Somayaji, S.N.; Vidyasagar, M.S.; Baliga, M.S. 2003: Evaluation of intraperitoneal vincristine in malignant peritoneal effusion Indian Journal of Physiology and Pharmacology 47(3): 270-278
Reynolds, P.M.; Byrne, M.J. 1977: The treatment of malignant pericardial effusion in carcinoma of the breast Australian and New Zealand Journal of Medicine 7(2): 169-171
Rodríguez López, I.; Casal Iglesias, L.; Carballo Fernández, C.; Lado Lado, F. 1985: Pleuropericardial effusion as the initial manifestation of malignant thymoma Medicina Clinica 84(9): 377-378
Griffin, S.; Fountain, W. 1989: Pericardio-peritoneal shunt for malignant pericardial effusion Journal of Thoracic and Cardiovascular Surgery 98(6): 1153-1154
Klein, M.; Kaminsky, P.; Reichert, S.; Brun, D.; Aubert, V.; Duc, M. 1991: Rise in CA 125 in a case of multivisceral tuberculosis without effusion Presse Medicale 20(20): 959-960
Flandes Aldeyturriaga, J.; Vidal Loures, R.; Delgado Pérez, E.; Ferrando Siscar, C. 1992: Massive pleural effusion as the first manifestation of malignant melanoma dissemination Revista Clinica Espanola 190(5): 283-284
Berman, K.; Fielding, L.P.; Richi, A.A. 1984: Diagnosis and treatment of malignant pericardial effusion: the subxiphoid approach Connecticut Medicine 48(11): 701-702
Wolters, U.; Türler, A. 1998: Treatment strategies in malignant pleural effusion of breast carcinoma Zentralblatt für Chirurgie 123(Suppl 5): 128-129
Yanardag, H.; Güneş, Y. 2005: Occurrence of pleural effusion due to tuberculosis in patients with sarcoidosis Indian Journal of Chest Diseases and Allied Sciences 47(1): 9-11
Nori, D.; Moorthy, C.R.; Hilaris, B.S.; Batata, M.A.; Chu, F.; Martini, N. 1981: Intrapleural instillation of radioactive chromic phosphate in malignant pleural effusion Indian Journal of Cancer 18(4): 288-291
Kawaoka, T.; Yoshino, S.; Hazama, S.; Tangoku, A.; Oka, M. 2003: Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1562-1565